Evidence map›Paper›PMID 42812644›Full record

ArticleOrthopedic reviews2026

Platelet-Rich Plasma Injections for Refractory Sacroiliac Joint Pain: A Two-Patient Case Series.

Jamal Hasoon, Christopher L Robinson, Ivan Urits

Abstract read
In one paragraph

Article in Orthopedic reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jamal Hasoon
Christopher L Robinson
Ivan Urits

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Sacroiliac joint (SIJ) pain is an important source of chronic axial low back and buttock pain. Initial treatment commonly includes activity modification, physical therapy, nonsteroidal anti-inflammatory drugs (NSAIDs), and other nonopioid medications. Interventional treatment options may include corticosteroid injections, radiofrequency ablation, and, in selected refractory cases, SIJ fusion. Platelet-rich plasma (PRP) is an autologous biologic injectate that has been investigated as an alternative treatment for low back pain disorders, although the available literature remains limited and conflicting. Case Presentation: We present two patients with refractory SIJ pain who underwent a single PRP injection after failing conservative and interventional treatment options. The first patient was a man in his 50s with persistent SIJ pain despite physical therapy, NSAIDs, and prior corticosteroid injections targeting the SIJ. Following a single PRP injection, he reported approximately 50% sustained pain relief at three-month follow-up. The second patient was a woman in her 50s with persistent SIJ pain despite physical therapy, NSAIDs, muscle relaxants, tramadol, and previous SIJ injections. Radiofrequency ablation was considered but was not covered by her insurance, and she did not wish to proceed with SIJ fusion. Following a single PRP injection, she reported approximately 75% sustained pain relief at four-month follow-up. Conclusion: PRP injection was associated with sustained improvement in pain in two patients with refractory SIJ pain after failure of multiple conventional treatments. These cases provide additional real-world clinical observations supporting further investigation of PRP as a potential nonsurgical option for carefully selected patients with persistent SIJ pain.

Indexed as

corticosteroid injection.intra-articular injectionlow back painorthobiologicsplatelet-rich plasmaregenerative medicinesacroiliac jointsacroiliac joint pain

Identifiers

PMID42812644
PMCPMC13621272

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.